Irritable bowel syndrome is a chronic condition characterized by discomfort and pain in the abdominal region. Sufferers also experience symptoms such as diarrhea, constipation and gas, and it is believed that the condition is adversely affected by anxiety. Anywhere between 25 and 45 million people are affected by IBS in the United States alone, and 2 out of 3 IBS patients are women. The unfortunate reality for IBS sufferers is that there are few effective long-term treatments that manage symptoms without the risk of side effects. As a result, the IBS market presents plenty of opportunities for alternative treatment methods to make a positive impact on patients worldwide.
Medical Marijuana Products
Pharmaceutical industry experts predict that the market for cannabis products could reach 10 percent of the specialty market by the year 2020, with a market value of $20 billion. With a variety of cannabinoids to test and incorporate …